Status
Conditions
Treatments
About
CANPOS is a non-interventional study aiming at evaluate at the time of initial surgery the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer. This would represent a rational to develop personalized follow-up and prevention strategies
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Exclusion criteria were:
250 participants in 1 patient group
Loading...
Central trial contact
Cyrille Confavreux; Nicolas Girard
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal